These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23159495)

  • 1. Pairwise antibody footprinting using surface plasmon resonance technology to characterize human papillomavirus type 16 virus-like particles with direct anti-HPV antibody immobilization.
    Towne V; Zhao Q; Brown M; Finnefrock AC
    J Immunol Methods; 2013 Feb; 388(1-2):1-7. PubMed ID: 23159495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping by surface plasmon resonance.
    Säfsten P
    Methods Mol Biol; 2009; 524():67-76. PubMed ID: 19377937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope clustering analysis for vaccine-induced human antibodies in relationship to a panel of murine monoclonal antibodies against HPV16 viral capsid.
    Zhang C; Huang X; Chen S; Li Y; Li Y; Wang X; Tang J; Xia L; Lin Z; Luo W; Li T; Li S; Zhang J; Xia N; Zhao Q
    Vaccine; 2018 Oct; 36(45):6761-6771. PubMed ID: 30287156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the binding of monoclonal and polyclonal antibodies to the glycoproteins of antigenic variants of human respiratory syncytial virus by surface plasmon resonance.
    McGill A; Marsh R; Craft AW; Toms GL
    J Immunol Methods; 2005 Feb; 297(1-2):143-52. PubMed ID: 15777938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5.
    Xia L; Xian Y; Wang D; Chen Y; Huang X; Bi X; Yu H; Fu Z; Liu X; Li S; An Z; Luo W; Zhao Q; Xia N
    Sci Rep; 2016 Jan; 6():19042. PubMed ID: 26750243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A deletion and point mutation study of the human papillomavirus type 16 major capsid gene.
    Varsani A; Williamson AL; Jaffer MA; Rybicki EP
    Virus Res; 2006 Dec; 122(1-2):154-63. PubMed ID: 16938363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Establishment and application of human papillomavirus type 16 pseudovirions neutralization assay].
    Lu WX; Cheng T; Li SW; Pan HR; Shen WT; Chen YX; Zhang T; Zheng Z; Zhang J; Xia NS
    Sheng Wu Gong Cheng Xue Bao; 2006 Nov; 22(6):990-5. PubMed ID: 17168325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-depth process understanding of RECOMBIVAX HB® maturation and potential epitope improvements with redox treatment: multifaceted biochemical and immunochemical characterization.
    Zhao Q; Towne V; Brown M; Wang Y; Abraham D; Oswald CB; Gimenez JA; Washabaugh MW; Kennedy R; Sitrin RD
    Vaccine; 2011 Oct; 29(45):7936-41. PubMed ID: 21871939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines.
    Da Silva DM; Pastrana DV; Schiller JT; Kast WM
    Virology; 2001 Nov; 290(2):350-60. PubMed ID: 11883199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/cottontail rabbit papillomavirus chimeric papillomavirus particles.
    Mejia AF; Culp TD; Cladel NM; Balogh KK; Budgeon LR; Buck CB; Christensen ND
    J Virol; 2006 Dec; 80(24):12393-7. PubMed ID: 17005666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV11 mutant virus-like particles elicit immune responses that neutralize virus and delineate a novel neutralizing domain.
    Ludmerer SW; McClements WL; Wang XM; Ling JC; Jansen KU; Christensen ND
    Virology; 2000 Jan; 266(2):237-45. PubMed ID: 10639310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.
    Liu XS; Abdul-Jabbar I; Qi YM; Frazer IH; Zhou J
    Virology; 1998 Dec; 252(1):39-45. PubMed ID: 9875315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants.
    Revaz V; Zurbriggen R; Moser C; Schiller JT; Ponci F; Bobst M; Nardelli-Haefliger D
    Antiviral Res; 2007 Oct; 76(1):75-85. PubMed ID: 17617476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage display for site-specific immunization and characterization of high-risk human papillomavirus specific E7 monoclonal antibodies.
    Lidqvist M; Nilsson O; Holmgren J; Hall C; Fermér C
    J Immunol Methods; 2008 Sep; 337(2):88-96. PubMed ID: 18606164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method for the simultaneous assay of the different poliovirus types using surface plasmon resonance technology.
    Manin C; Naville S; Gueugnon M; Dupuy M; Bravo de Alba Y; Adam O
    Vaccine; 2013 Feb; 31(7):1034-9. PubMed ID: 23277095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of antibody-antigen interactions: comparison between surface plasmon resonance measurements and high-mass matrix-assisted laser desorption/ionization mass spectrometry.
    Bich C; Scott M; Panagiotidis A; Wenzel RJ; Nazabal A; Zenobi R
    Anal Biochem; 2008 Apr; 375(1):35-45. PubMed ID: 18078803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33.
    Roth SD; Sapp M; Streeck RE; Selinka HC
    Virol J; 2006 Oct; 3():83. PubMed ID: 17014700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time analysis of antibody interactions with whole enveloped human cytomegalovirus using surface plasmon resonance.
    Chenail G; Brown NE; Shea A; Feire AL; Deng G
    Anal Biochem; 2011 Apr; 411(1):58-63. PubMed ID: 21167121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of neutralizing antibodies to papillomaviruses by anti-idiotypic antibodies.
    Christensen ND; Reed CA; Cladel NM
    Virology; 1995 Jul; 210(2):292-301. PubMed ID: 7542415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.